Aclaris therapeutics to participate in two march healthcare conferences

Wayne, pa., march 04, 2025 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the company will participate in two upcoming healthcare conferences in march. on tuesday march 11, 2025, at 3:00 pm edt, aclaris' chief executive officer dr. neal walker and other members of aclaris' senior leadership team will participate in a fireside chat during the leerink partners global healthcare conference in miami, florida.
ACRS Ratings Summary
ACRS Quant Ranking